熱門資訊> 正文

enVVeno Medical报告第二季度业绩

2025-08-01 20:45

enVVeno Medical press release (NASDAQ:NVNO): Q2 The Company reported net losses of $6.7 million and $5.0 million for the three months ended June 30, 2025 and 2024, respectively, representing an increase in net loss of $1.7 million, or 35%.
Cash burn for the quarter was $3.8 million, consistent with the Company's projected cash burn rate of approximately $4-5 million per quarter.

More on enVVeno Medical

Seeking Alpha’s Quant Rating on enVVeno Medical
Historical earnings data for enVVeno Medical
Financial information for enVVeno Medical

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。